Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-021846

President and CEO sold 5,475 shares at an average $0.49 ($2,710)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-31 Sale : show line 1 in the form 10b5-1 −2,676 $0.50 $1,338 675,407 D
2023-08-01 Sale : show line 2 in the form 10b5-1 −2,799 $0.49 $1,372 672,608 D
Open-market sales · 5,475 sh · avg $0.49 · $2,710
Loading xslF345X05/form4.xml…